IVUS + NIRS: The PROSPECT II Study Published on The Lancet

11 March 2021

The PROSPECT II Study has been published in the current issue of The Lancet.

 

Study findings show that combined #NIRS and #IVUS detects angiographically non-obstructive lesions with a high lipid content and large plaque burden that are at increased risk for future adverse cardiac outcomes.

 

Click  The PROSPECT II Study to read more

 

Latest News:

EUKON GO GREEN

Caserta, ITALY – April 9, 2021 — With its mission…

Read More >

TOBI IRAN 2021 BREAKING NEWS!

February 26th and March 12th   EUKON & Insight Lifetech…

Read More >